0001127602-16-046606.txt : 20160316
0001127602-16-046606.hdr.sgml : 20160316
20160316173524
ACCESSION NUMBER: 0001127602-16-046606
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160315
FILED AS OF DATE: 20160316
DATE AS OF CHANGE: 20160316
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alkermes plc.
CENTRAL INDEX KEY: 0001520262
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981007018
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
BUSINESS PHONE: 00-353-1-772-8000
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC
DATE OF NAME CHANGE: 20110804
FORMER COMPANY:
FORMER CONFORMED NAME: Antler Science Two Ltd
DATE OF NAME CHANGE: 20110509
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: POPS RICHARD F
CENTRAL INDEX KEY: 0001126490
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35299
FILM NUMBER: 161510634
MAIL ADDRESS:
STREET 1: 10555 SCIENCE CENTER DR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2016-03-15
0001520262
Alkermes plc.
ALKS
0001126490
POPS RICHARD F
CONNAUGHT HOUSE
1 BURLINGTON ROAD
DUBLIN 4 IRELAND
1
1
Director and CEO, Alkermes plc
Ordinary Shares
2016-03-15
4
M
0
4810
20.79
A
581307
D
Ordinary Shares
2016-03-15
4
M
0
20190
20.79
A
601497
D
Ordinary Shares
2016-03-15
4
S
0
25000
31.3964
D
576497
D
Incentive Stock Option (Right to Buy)
20.79
2016-03-15
4
M
0
4810
0
D
2016-05-02
Ordinary Shares
4810
0
D
Non Qualified Stock Option (Right to Buy)
20.79
2016-03-15
4
M
0
20190
0
D
2016-05-02
Ordinary Shares
20190
68750
D
This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.09 to $31.79. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
These options are fully vested in accordance with their terms.
/s/ Jennifer Baptiste, attorney-in-fact for Richard F. Pops
2016-03-16